Business - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Business
News, articles, and updates about business activities in the bio/pharmaceutical industry.

Lilly to Close Manufacturing Facility in Puerto Rico

October 17, 2014

Lilly announces the closure of its Guayama, Puerto Rico manufacturing facility amid continued investments at other plants.

AbbVie Reconsiders Shire Offer

October 15, 2014

AbbVie sends Shire notice that it is reconsidering its offer recommendation.

Marrying Big Data with Personalized Medicine

October 2, 2014
Pharmaceutical Technology

Data analytic strategies can help companies capitalize on personalized medicine.

GSK Fined in China Bribery Scandal

September 19, 2014

GSK is found guilty of offering bribes to doctors and is fined $489 million.

AbbVie to Acquire Shire for $54.7 Billion

July 18, 2014

After rejecting several bids, Shire has agreed to a merger with AbbVie valued at almost $55 billion.

Mylan to Acquire Abbott's Non-US Businesses in $5.3 Billion Stock Deal

July 14, 2014

Mylan set to acquire Abbott's non-US developed markets specialty and branded generics business in an all-stock transaction.

Changing Market Dynamics Require New Approaches to Innovation

June 29, 2014
PTSM: Pharmaceutical Technology Sourcing and Management

Pharma companies are looking to external sources for innovations that meet future needs.

Pharma Capacity to Produce Cytotoxic Injectable Drugs Constricts

June 29, 2014
PTSM: Pharmaceutical Technology Sourcing and Management

PharmSource special report shows demand for cytotoxic injectable drugs could tap existing CMO capacity.

More than 430 New Medicines in Development for Chronic Diseases

June 26, 2014

PTSM: Pharmaceutical Technology Sourcing and Management

PhRMA announced 430 new medicines in development to treat chronic diseases affecting older Americans.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
29%
Oversee medical treatment of patients in the US.
10%
Provide treatment for patients globally.
6%
All of the above.
42%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here